Antiviral drug discovery for emerging diseases and bioterrorism threats edited by Paul F. Torrence

Text Registration

Antiviral drug discovery for emerging diseases and bioterrorism threats edited by Paul F. Torrence

Status

Published

on 15 Jun 2007

Year of Creation

2004

John Wiley & Sons, Inc. (employer for hire in pref., collective work & contributions)

Registration Number

TX0006229465

on 15 Jun 2007

The U.S. Copyright record (Registration Number: TX0006229465) dated 15 Jun 2007, pertains to an electronic file (eService) titled "Antiviral drug discovery for emerging diseases and bioterrorism threats edited by Paul F. Torrence" created in 2004. The copyright holder is John Wiley & Sons, Inc. (employer for hire in pref., collective work & contributions), known for their creative contributions in text registration. For any inquiries concerning this copyrighted material, kindly reach out to John Wiley & Sons, Inc. (employer for hire in pref., collective work & contributions).

John Wiley & Sons, Inc. (employer for hire in pref., collective work & contributions)

Application Details

Registration Number

TX0006229465

Registration Date

6/15/2007

Year of Creation

2004

Agency Marc Code

DLC-CO

Record Status

Changed

Personal Authors

Paul F Torrence

Corporate Authors

Inc John Wiley & Sons

Notes

Local Copyright Note: Cataloged from appl. only

Material Matter Claimed Note: New Matter: pref., collective work & contributions

Previous Registration Note: Some material prev. pub

Notes

Local Copyright Note: Cataloged from appl. only

Material Matter Claimed Note: New Matter: pref., collective work & contributions

Previous Registration Note: Some material prev. pub

Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

Show terms & conditions

Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal advice. Although LegalForce RAPC Worldwide P.C., dba Trademarkia P.C., is a law firm (the “Firm”), your use of this website does not establish an attorney-client relationship with the Firm. Such a relationship can only be established after the Firm decides that it is willing and able to accept the engagement after a conflict check and after a written retainer agreement is agreed upon between you and the Firm. Your use of this website is also subject to our Terms of Use and Privacy Policy. ** The entry level subscription is a bundled price which requires a minimum of two billing cycles, or 6 months.